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To the Editor:
The association of chronic renal failure (CRF)
to erectile dysfunction (ED) is a well known fact, but
the prevalence of ED obtained in this population is
variable. The lack of an standardised instrument for
ED assessment before generalisation of the
international index of erectile function (IIEF) and the
heterogeneity of CRF patients regarding the presence
of commorbidities are two facts that have probably
contributed to this variability. However, a high
prevalence of ED has generally been reported in CRF
patients. In this sense, Messina and collaborators
report in this issue that the prevalence of ED in a
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study population of brazilian men suffering from CRF
and undergoing hemodialysis was 60.3%. This means
that a large number of patients undergoing hemodialysis
also complaint from ED. When ED is added to the
deterioration in quality of life caused by the renal failure
as the need to stay several hours per day, three times a
week, connected to the hemodialysis machine, the
decline of the quality of life becomes harder. The
prevalence reported in this study is not far from that
reported by other authors in CRF patients in Brazil (1)
which was 57.9%. In addition, age is a variable
associated with ED in both studies. The present study,
also confirms that diabetes is a main factor associated
to ED in patients undergoing hemodialysis. In fact,
almost all diabetic patients with CRF presented ED.
Since diabetes is independently associated to ED, this
could indicate that the presence of two risk factors
prompts the patient to develop ED. Diabetes is related
to a reduction of nitric oxide (NO)-mediated activity
(2) while CRF has also been suggested to decrease NO
availability (3,4). Thus, the presence of the two
conditions should hardly impact the NO/cGMP
pathway, a key pathway in the erection process. Due
to the high proportion of hypertensive patients in this
study, authors cannot evaluate the association of
hypertension with ED in patients undergoing
hemodyalisis. However, interesting information could
have been obtained by analysing the relationship
between ED and the specific antihypertensive
medication. A novel finding of the study by Messina
and collaborators is that ED correlated with parameters
of hemodialysis adequacy (Kt/V) suggesting that ED
could be prevented by achieving good standards of
dialysis. The lower risk for ED when urea is effectively
cleared from plasma is consistent with the fact that
uraemia results in reduced bioavailability of NO (5)
and the serum levels of endogenous inhibitors of NO
synthase are increased in uraemic patients (6). In
conclusion, the high prevalence of ED among the
patients with CRF compels practitioners to ask for
erectile function of these patients, in order to try to
improve their quality of life. A better understanding of
the specific pathophysiological mechanisms leading to
ED in CRF patients could help to find the adequate
treatment option.
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